Kelsey Goodwin
Stock Analyst at Piper Sandler
(3.86)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics | Initiates Coverage On: Neutral | 21 | 18.27 | 14.94% | 1 | Aug 19, 2025 | |
JANX Janux Therapeutics | Initiates Coverage On: Overweight | 42 | 24.34 | 72.56% | 1 | Aug 19, 2025 | |
RVMD Revolution Medicines | Initiates Coverage On: Overweight | 75 | 45.37 | 65.31% | 1 | Aug 19, 2025 | |
URGN UroGen Pharma | Initiates Coverage On: Overweight | 36 | 19.38 | 85.76% | 4 | Aug 19, 2025 | |
CGON CG Oncology | Initiates Coverage On: Overweight | 55 | 33.38 | 64.77% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 11 | 6.5 | 69.23% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 112 | 81.7 | 37.09% | 3 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 36 | 11.8 | 205.08% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | n/a | n/a | n/a | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 3.6 | 122.22% | 1 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | n/a | n/a | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 |